A detailed history of Black Rock Inc. transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,818,546 shares of ZNTL stock, worth $15.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,818,546
Previous 4,645,758 3.72%
Holding current value
$15.3 Million
Previous $73.2 Million 73.08%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$4.09 - $16.13 $706,702 - $2.79 Million
172,788 Added 3.72%
4,818,546 $19.7 Million
Q1 2024

May 10, 2024

SELL
$10.83 - $16.49 $424,720 - $646,688
-39,217 Reduced 0.84%
4,645,758 $73.2 Million
Q4 2023

Feb 13, 2024

BUY
$9.84 - $20.13 $2.84 Million - $5.82 Million
289,118 Added 6.58%
4,684,975 $71 Million
Q3 2023

Nov 13, 2023

BUY
$19.63 - $28.29 $8.74 Million - $12.6 Million
445,053 Added 11.26%
4,395,857 $88.2 Million
Q2 2023

Aug 11, 2023

BUY
$17.41 - $30.05 $9.29 Million - $16 Million
533,337 Added 15.61%
3,950,804 $111 Million
Q1 2023

May 12, 2023

SELL
$16.14 - $24.94 $883,051 - $1.36 Million
-54,712 Reduced 1.58%
3,417,467 $58.8 Million
Q4 2022

Feb 13, 2023

BUY
$18.07 - $25.6 $2.46 Million - $3.48 Million
136,113 Added 4.08%
3,472,179 $69.9 Million
Q3 2022

Nov 14, 2022

BUY
$20.23 - $31.73 $1.92 Million - $3.01 Million
95,008 Added 2.93%
3,336,066 $72.3 Million
Q2 2022

Aug 12, 2022

BUY
$17.91 - $52.25 $7.14 Million - $20.8 Million
398,478 Added 14.02%
3,241,058 $91.1 Million
Q1 2022

May 12, 2022

SELL
$41.58 - $80.89 $15,176 - $29,524
-365 Reduced 0.01%
2,842,580 $131 Million
Q4 2021

Feb 10, 2022

BUY
$66.92 - $84.79 $5.83 Million - $7.39 Million
87,157 Added 3.16%
2,842,945 $239 Million
Q3 2021

Nov 09, 2021

BUY
$46.83 - $73.5 $20.4 Million - $32 Million
435,672 Added 18.78%
2,755,788 $184 Million
Q2 2021

Aug 11, 2021

BUY
$37.41 - $62.25 $86.8 Million - $144 Million
2,320,116 New
2,320,116 $123 Million

Others Institutions Holding ZNTL

About Zentalis Pharmaceuticals, Inc.


  • Ticker ZNTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,983,600
  • Market Cap $181M
  • Description
  • Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...
More about ZNTL
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.